Back to top
more

Xylem (XYL)

(Delayed Data from NYSE)

$134.39 USD

134.39
1,377,559

-0.64 (-0.47%)

Updated Oct 1, 2024 04:00 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value D Growth C Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 24% (191 out of 252)

Industry: Manufacturing - General Industrial

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

LXFR vs. XYL: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

LXFR vs. XYL: Which Stock Is the Better Value Option?

Xylem (XYL) Surpasses Q2 Earnings Estimates, Provides View

by Zacks Equity Research

Xylem's (XYL) Q2 results reflect the adverse impacts of the pandemic, weak margins and forex woes. Sequential improvements are expected in organic sales and adjusted operating margin in Q3.

Xylem (XYL) Beats Q2 Earnings and Revenue Estimates

by Zacks Equity Research

Xylem (XYL) delivered earnings and revenue surprises of 2.56% and 0.47%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Illinois Tool (ITW) to Report Q2 Earnings: What's in Store?

by Zacks Equity Research

Illinois Tool (ITW) Q2 results are likely to reflect the pandemic impact, especially on automotive OEM businesses. Diversified businesses, enterprise strategy and cost-cutting might have aided.

Avisekh Bhattacharjee headshot

Industrial Stock Q2 Earnings Due on Jul 30: SWK, XYL & More

by Avisekh Bhattacharjee

The impacts of the coronavirus outbreak, cost-related woes and other headwinds are expected to get reflected in the results of the majority of industrial stocks in Q2.

Xylem (XYL) to Report Q2 Earnings: What's in the Cards?

by Zacks Equity Research

Xylem's (XYL) Q2 results are expected to reflect the adverse impacts of the pandemic on its operations. Solid contract wins, product offerings and cost-management are likely to have been tailwinds.

Payal Jalan headshot

5 Industrial Stocks Poised for an Earnings Beat in Q2

by Payal Jalan

Industrial product stocks are expected to reflect gains from the pandemic-led product demand, spur in e-commerce and cost-saving measures. We present five stocks poised for an earnings beat in Q2.

Xylem (XYL) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

by Zacks Equity Research

Xylem (XYL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

FLS vs. XYL: Which Stock Is the Better Value Option?

by Zacks Equity Research

FLS vs. XYL: Which Stock Is the Better Value Option?

Xylem (XYL) Provides Update on Q2 results, Confirms Deal Wins

by Zacks Equity Research

Xylem (XYL) provides a financial update for second-quarter results. Also, it secures two significant contracts in the second quarter.

LXFR vs. XYL: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

LXFR vs. XYL: Which Stock Is the Better Value Option?

Xylem (XYL) Displays Bright Prospects Despite Headwinds

by Zacks Equity Research

Xylem (XYL) is likely to benefit from new products, innovation and focus on operational execution in the quarters ahead. However, soft end markets amid the coronavirus pandemic are concerning.

Xylem (XYL) Declines 19% YTD: What's Affecting the Stock?

by Zacks Equity Research

Xylem (XYL), with shares down 19% so far in 2020, faces risks from difficult end-market conditions due to the pandemic, forex woes and cost inflation. Q2 organic sales are likely to fall 20-30% y/y.

Why Is Xylem (XYL) Up 11.1% Since Last Earnings Report?

by Zacks Equity Research

Xylem (XYL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Danaher's Stock Offering Proceeds to Fund Corporate Needs

by Zacks Equity Research

Danaher (DHR) completes the offering of common and convertible preferred shares. It intends on using the funds raised to pay for its corporate needs.

Xylem (XYL) Q1 Earnings Lag Estimates, Organic View Weak

by Zacks Equity Research

Xylem's (XYL) Q1 results reflect the adverse impacts of the coronavirus outbreak, a fall in margins and forex woes. Organic sales in Q2 are expected to reflect the uncertainties as well.

Xylem (XYL) Misses Q1 Earnings and Revenue Estimates

by Zacks Equity Research

Xylem (XYL) delivered earnings and revenue surprises of -37.84% and -1.79%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

Xylem (XYL) to Report Q1 Earnings: What's in the Offing?

by Zacks Equity Research

Xylem's (XYL) Q1 results are expected to reflect the adverse impacts of the uncertainties caused by the coronavirus outbreak. But healthy balance sheet and cost actions might have aided.

Analysts Estimate Xylem (XYL) to Report a Decline in Earnings: What to Look Out for

by Zacks Equity Research

Xylem (XYL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Payal Jalan headshot

How are Industrial Product Stocks Placed for Q1 Earnings?

by Payal Jalan

The coronavirus outbreak mars earnings and revenue prospects for many companies under the Industrial Products sector. Collective results for the first quarter of 2020 might be lackluster.

Avisekh Bhattacharjee headshot

Drab Near-Term Prospects for Industrial Manufacturing Stocks

by Avisekh Bhattacharjee

The Manufacturing - General Industrial industry is facing coronavirus-related issues, job losses & other problems. Technological advancement in manufacturing processes will likely be a growth driver.

NPO vs. XYL: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

NPO vs. XYL: Which Stock Is the Better Value Option?

Flowserve (FLS) Withdraws Annual View on Coronavirus Concerns

by Zacks Equity Research

Flowserve (FLS) withdraws guidance for 2020, owing to uncertainties in the end-markets on the impacts of the coronavirus outbreak.

Xylem (XYL) Withdraws Guidance Based on Coronavirus Concerns

by Zacks Equity Research

Xylem (XYL) withdraws guidance for the first quarter and 2020, owing to the coronavirus outbreak.

NPO vs. XYL: Which Stock Is the Better Value Option?

by Zacks Equity Research

NPO vs. XYL: Which Stock Is the Better Value Option?